Frederic Brosseron
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Glycosylation and Glycoproteins Research 5
- S100 Proteins and Annexins 4
-
- Neuroinflammation and Neurodegeneration Mechanisms 7
- Co-authors
- Michael T. Heneka (17 shared papers)Markus P. Kummer (5 shared papers)Marius Krauthausen (1 shared paper)Katrin Marcus (8 shared papers)Stephanie Schwartz (3 shared papers)Francesco Santarelli (5 shared papers)Marija Jankunec (1 shared paper)Cira Dansokho (1 shared paper)
- Journals
- Alzheimer s & Dementia (4 papers)Journal of Neurochemistry (3 papers)Molecular Neurobiology (2 papers)Alzheimer s Research & Therapy (2 papers)Journal of Alzheimer s Disease (1 paper)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Frederic Brosseron
26 papers receiving 994 citations
Peers
Comparison fields: 5 of 93
- Biological Psychiatry 158
- Neurology 330
- Physiology 340
- Developmental Neuroscience 23
- Behavioral Neuroscience 20
Countries citing papers authored by Frederic Brosseron
This map shows the geographic impact of Frederic Brosseron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Brosseron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Brosseron more than expected).
Fields of papers citing papers by Frederic Brosseron
This network shows the impact of papers produced by Frederic Brosseron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Brosseron. The network helps show where Frederic Brosseron may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederic Brosseron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 345 | |
| 2 | 2019 | 151 | |
| 3 | 2018 | 78 | |
| 4 | 2011 | 67 | |
| 5 | 2021 | 54 | |
| 6 | 2022 | 45 | |
| 7 | 2010 | 35 | |
| 8 | 2024 | 34 | |
| 9 | 2019 | 31 | |
| 10 | 2019 | 30 | |
| 11 | 2019 | 27 | |
| 12 | 2020 | 17 | |
| 13 | 2015 | 13 | |
| 14 | 2012 | 13 | |
| 15 | 2012 | 12 | |
| 16 | 2012 | 11 | |
| 17 | 2021 | 9 | |
| 18 | 2020 | 8 | |
| 19 | 2017 | 6 | |
| 20 | 2025 | 2 |
About Frederic Brosseron
Frederic Brosseron is a scholar working on Molecular Biology, Neurology, Spectroscopy, Physiology and Critical Care and Intensive Care Medicine, having authored 27 papers that have together received 996 indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Mass Spectrometry Techniques and Applications (7 papers), Alzheimer's disease research and treatments (5 papers), Glycosylation and Glycoproteins Research (5 papers), S100 Proteins and Annexins (4 papers), Intensive Care Unit Cognitive Disorders (2 papers) and Cerebrospinal fluid and hydrocephalus (1 paper). The work is most often cited by research in Biological Psychiatry (158 citations), Neurology (330 citations), Physiology (340 citations), Developmental Neuroscience (23 citations) and Behavioral Neuroscience (20 citations). Frederic Brosseron has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Michael T. Heneka, Markus P. Kummer, Marius Krauthausen, Katrin Marcus, Stephanie Schwartz, Francesco Santarelli, Marija Jankunec, Cira Dansokho, Róisín M. McManus and Caroline May. Their work appears in journals such as Alzheimer s & Dementia, Journal of Neurochemistry, Molecular Neurobiology, Alzheimer s Research & Therapy and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.